Please E-mail suggested additions, comments and/or corrections to Kent@MoreLaw.Com.
Help support the publication of case reports on MoreLaw
Teva Pharmaceuticals, USA, Inc., et al. v. Sandoz, Inc. et al.
Date: 10-12-2018
Case Number: 2917-1575
Judge: Reyna, Beyson, and Stroll
Court: United States Court of Appeals for the Federal Circuit on appeal from the United States Court of District Court for the District of Delaware
Plaintiff's Attorney:
Defendant's Attorney: Deanne Maynard, et al.
Inc., Teva Pharmaceutical Industries, Ltd., Teva Neuro-
science, Inc., and Yeda Research and Development Co.,
Ltd., appeal the decision of the United States District
Court for the District of Delaware invalidating all assert-
ed claims of patents directed to COPAXONE® 40mg/mL, a
product marketed for treatment of patients with relapsing
forms of multiple sclerosis.
See: Full Opinion
correctly held the asserted claims invalid as obvious
under 35 U.S.C. § 103, we affirm.
About This Case
What was the outcome of Teva Pharmaceuticals, USA, Inc., et al. v. Sandoz, Inc. e...?
The outcome was: Because the district court correctly held the asserted claims invalid as obvious under 35 U.S.C. § 103, we affirm.
Which court heard Teva Pharmaceuticals, USA, Inc., et al. v. Sandoz, Inc. e...?
This case was heard in United States Court of Appeals for the Federal Circuit on appeal from the United States Court of District Court for the District of Delaware, DE. The presiding judge was Reyna, Beyson, and Stroll.
Who were the attorneys in Teva Pharmaceuticals, USA, Inc., et al. v. Sandoz, Inc. e...?
Plaintiff's attorney: . Defendant's attorney: Deanne Maynard, et al..
When was Teva Pharmaceuticals, USA, Inc., et al. v. Sandoz, Inc. e... decided?
This case was decided on October 12, 2018.